Olympus Corporation: Study Results Show Long-term Efficacy of iTind Procedure

Abstract of Durability Study Results for iTind Procedure Presented at 2022 American Urological Association Annual Meeting CENTER VALLEY, Pa. and HAMBURG, Germany, May 18, 2022 /PRNewswire/

Related Keywords

Germany ,Italy ,Hamburg ,United States ,American ,Vanessa Malka ,Francesco Porpiglia ,Urol Nephrol ,Urology Care Foundation ,University Of Turin ,Urology Division At San Luigi Gonzaga Hospital ,American Urological Association Annual Meeting ,Tind Commercial Head For Olympus Corporation ,Olympus Corporation ,International Prostate Symptom Score ,Durability Study Results ,Tind Procedure Presented ,Urological Association Annual Meeting ,Professor Francesco Porpiglia ,Urology Division ,San Luigi Gonzaga Hospital ,Executive Director ,Tind Commercial Head ,International Multicenter Prospective Study ,Temporary Implantable Nitinol Device ,Lower Urinary Tract Symptoms ,Benign Prostatic Hyperplasia ,Updated September ,Eurology Care ,Accessed November ,Tind Temporarily Implanted Nitinol Device ,Lower Urinary Tract Symptoms Secondary ,Controlled Trial ,Olympus ,Corporation ,Study ,Results ,Show ,Song ,Term ,Efficacy ,Vstind ,Procedure ,